There you read the following:
Audience: Individuals Performing COVID-19 Testing
Level: Laboratory Alert
After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only. CDC is providing this advance notice for clinical laboratories to have adequate time to select and implement one of the many FDA-authorized alternatives.
In preparation for this change, CDC recommends clinical laboratories and testing sites that have been using the CDC 2019-nCoV RT-PCR assay select and begin their transition to another FDA-authorized COVID-19 test. CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses. Such assays can facilitate continued testing for both influenza and SARS-CoV-2 and can save both time and resources as we head into influenza season. Laboratories and testing sites should validate and verify their selected assay within their facility before beginning clinical testing.
The bold text means that the PCR test used so far to drive the plandemic globally cannot distinguish the alleged COVID-19 causing SARS-CoV-2 virus from influenza viruses. As a result they are withdrawing their EUA on its use for the detection of the so-called 2019-Novel Coronavirus.
It has all been smoke and mirrors folks. There never was a COVID-19 pandemic and now these Emperor is exposed with no clothes.
Comments welcome below.
Join me on Telegram.com: @GideonHartnett https://t.me/gideonhartnett
If you want to be notified by email each time I add a new post click the “Email” button below and add you email address.